AlphaFold predicted structure
CD55 · P08174

Mean pLDDT
78.3/ 100
Confident
381 residues
Confidence breakdown
- Very high(≥ 90)65%
- Confident(70–90)1%
- Low(50–70)5%
- Very low(< 50)29%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
CD55 molecule (Cromer blood group)
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
COVID-19 research
BIALLELIC, autosomal or pseudoautosomalIntestinal failure or congenital diarrhoea
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalProtein-losing enteropathy
primary intestinal lymphangiectasia
complement deficiency
refractive error
myopia
Hypermetropia
diverticular disease
macular degeneration
cervical carcinoma
Venous thrombosis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Complement decay-accelerating factor
This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade (PubMed:7525274). Inhibits complement activation by destabilizing and preventing the formation of C3 and C5 convertases, which prevents complement damage (PubMed:28657829)
CD55 · P08174

Mean pLDDT
78.3/ 100
Confident
381 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0